{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:41:02Z","timestamp":1790804462283,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00449","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T23:24:45Z","timestamp":1520292285000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures"],"prefix":"10.3389","volume":"9","author":[{"given":"Marzia","family":"Dolcino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera Filomena","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Patuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Tinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/0961203314558677","article-title":"Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage","volume":"24","author":"Dolcino","year":"2015","journal-title":"Lupus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","article-title":"Systemic sclerosis: genetics and epigenetics","volume":"41","author":"Luo","year":"2013","journal-title":"J Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.autrev.2016.01.016","article-title":"Genetic factors and systemic sclerosis","volume":"15","author":"Murdaca","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.autrev.2017.03.012","article-title":"Novel risk factors related to cancer in scleroderma","volume":"16","author":"Bernal-Bello","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/art.40065","article-title":"Brief report: anti-RNPC-3 antibodies as a marker of cancer-associated scleroderma","volume":"69","author":"Shah","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jmv.2016.07.001","article-title":"Paraneoplastic systemic sclerosis: about 3 cases and review of literature","volume":"41","author":"Monfort","year":"2016","journal-title":"J Mal Vasc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/BOR.0000000000000222","article-title":"Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening","volume":"27","author":"Shah","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.coi.2012.07.011","article-title":"MicroRNAs and autoimmunity","volume":"24","author":"Ceribelli","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu Rev Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.intimp.2015.07.042","article-title":"Critical roles of microRNAs in the pathogenesis of systemic sclerosis: new advances, challenges and potential directions","volume":"28","author":"Miao","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1038\/emm.2013.71","article-title":"MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma","volume":"45","author":"Zhu","year":"2013","journal-title":"Exp Mol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00403-013-1410-1","article-title":"The role of microRNAs in skin fibrosis","volume":"305","author":"Babalola","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/rheumatology\/kes120","article-title":"microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma","volume":"51","author":"Sing","year":"2012","journal-title":"Rheumatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s10875-013-9896-z","article-title":"MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression","volume":"33","author":"Zhu","year":"2013","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B20","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-60761-175-2_7","article-title":"PANTHER pathway: an ontology-based pathway database coupled with data analysis tools","volume":"563","author":"Mi","year":"2009","journal-title":"Methods Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"D412","DOI":"10.1093\/nar\/gkn760","article-title":"STRING 8 \u2013 a global view on proteins and their functional interactions in 630 organisms","volume":"37","author":"Jensen","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nature03607","article-title":"Uncovering the overlapping community structure of complex networks in nature and society","volume":"435","author":"Palla","year":"2005","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene expression data using Cytoscape","volume":"2","author":"Cline","year":"2007","journal-title":"Nat Protoc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s13277-015-3878-0","article-title":"Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancer","volume":"37","author":"Gao","year":"2016","journal-title":"Tumour Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.3390\/biom7030053","article-title":"MYC-driven pathways in breast cancer subtypes","volume":"7","author":"Fallah","year":"2017","journal-title":"Biomolecules"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nm.4213","article-title":"PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression","volume":"22","author":"Horiuchi","year":"2016","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.drudis.2015.06.010","article-title":"Implications of Akt2\/Twist crosstalk on breast cancer metastatic outcome","volume":"20","author":"Pereira","year":"2015","journal-title":"Drug Discov Today"},{"key":"B30","first-page":"75","article-title":"Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review","volume":"25","author":"Pignataro","year":"2005","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1158\/1541-7786.MCR-14-0674-T","article-title":"Transposon mutagenesis screen identifies potential lung cancer drivers and CUL3 as a tumor suppressor","volume":"13","author":"Dorr","year":"2015","journal-title":"Mol Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1172\/JCI87532","article-title":"Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury","volume":"127","author":"Leaf","year":"2017","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2017.06.011","article-title":"Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS\/MAPK pathway","volume":"403","author":"Wang","year":"2017","journal-title":"Cancer Lett"},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-012-2258-3","article-title":"Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6","volume":"136","author":"Podnos","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B35","doi-asserted-by":"publisher","first-page":"30212","DOI":"10.18632\/oncotarget.4901","article-title":"Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors","volume":"6","author":"Damiani","year":"2015","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11926-007-0013-2","article-title":"Current concepts in normal and defective angiogenesis: implications for systemic sclerosis","volume":"9","author":"Mulligan-Kehoe","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/joim.12690","article-title":"Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis","volume":"283","author":"Heldin","year":"2017","journal-title":"J Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.imlet.2004.08.013","article-title":"The link between PKCalpha regulation and cellular transformation","volume":"96","author":"Michie","year":"2005","journal-title":"Immunol Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.18632\/oncotarget.13532","article-title":"Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis","volume":"8","author":"Zeng","year":"2017","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00281-015-0508-2","article-title":"Matrix remodeling in systemic sclerosis","volume":"37","author":"Leask","year":"2015","journal-title":"Semin Immunopathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1002\/art.21973","article-title":"Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma","volume":"54","author":"Zhou","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"B43","doi-asserted-by":"publisher","first-page":"63691","DOI":"10.18632\/oncotarget.19475","article-title":"Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1\/snail in non-small cell lung cancer","volume":"8","author":"Hung","year":"2017","journal-title":"Oncotarget"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0178823","DOI":"10.1371\/journal.pone.0178823","article-title":"Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma","volume":"12","author":"Guo","year":"2017","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.4049\/jimmunol.172.11.7123","article-title":"Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts","volume":"172","author":"Asano","year":"2004","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/labinvest.2015.154","article-title":"Canonical Wnt signaling in systemic sclerosis","volume":"96","author":"Bergmann","year":"2016","journal-title":"Lab Invest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ctrv.2017.07.005","article-title":"Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: from laboratory to patients","volume":"59","author":"Janku","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"964842","DOI":"10.1155\/2015\/964842","article-title":"Wnt\/beta-Catenin signaling pathway in skin carcinogenesis and therapy","volume":"2015","author":"Li","year":"2015","journal-title":"Biomed Res Int"},{"key":"B49","doi-asserted-by":"publisher","first-page":"546318","DOI":"10.1155\/2013\/546318","article-title":"The role of epidermal growth factor receptor in cancer metastasis and microenvironment","volume":"2013","author":"Sasaki","year":"2013","journal-title":"Biomed Res Int"},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13578-017-0168-0","article-title":"TGF-beta in pancreatic cancer initiation and progression: two sides of the same coin","volume":"7","author":"Shen","year":"2017","journal-title":"Cell Biosci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"30092","DOI":"10.1016\/j.semcancer.2017.07.007","article-title":"Role of Forkhead Box Class O proteins in cancer progression and metastasis","author":"Kim","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/15384047.2015.1016662","article-title":"Hes1: a key role in stemness, metastasis and multidrug resistance","volume":"16","author":"Liu","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"B53","first-page":"8593","article-title":"Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1535-6108(03)00305-2","article-title":"No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cells","volume":"4","author":"Weng","year":"2003","journal-title":"Cancer Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5551\/jat.10.304","article-title":"Global analysis of shear stress-responsive genes in vascular endothelial cells","volume":"10","author":"Ohura","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"B56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0378-1119(98)00400-4","article-title":"Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases","volume":"220","author":"Guo","year":"1998","journal-title":"Gene"},{"key":"B57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1947601911411084","article-title":"Ras in cancer and developmental diseases","volume":"2","author":"Fernandez-Medarde","year":"2011","journal-title":"Genes Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of p53 in cell death and human cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1042\/EB0410187","article-title":"The ubiquitin-proteasome system and cancer","volume":"41","author":"Devoy","year":"2005","journal-title":"Essays Biochem"},{"key":"B61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.06.017","article-title":"JAK-STAT signaling in cancer: from cytokines to non-coding genome","volume":"87","author":"Pencik","year":"2016","journal-title":"Cytokine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4161\/cc.5.8.2685","article-title":"p38 MAPK in development and cancer","volume":"5","author":"Bradham","year":"2006","journal-title":"Cell Cycle"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2147\/OTT.S93164","article-title":"Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression","volume":"10","author":"Xu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellsig.2017.09.005","article-title":"GPCRs: emerging anti-cancer drug targets","volume":"41","author":"Nieto","year":"2017","journal-title":"Cell Signal"},{"key":"B65","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10555-017-9704-y","article-title":"Proteasome dysregulation in human cancer: implications for clinical therapies","volume":"36","author":"Chen","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/08830185.2017.1380200","article-title":"Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals","volume":"37","author":"Vidya","year":"2018","journal-title":"Int Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.autrev.2008.07.022","article-title":"Systemic sclerosis and infections","volume":"8","author":"Randone","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chom.2014.02.003","article-title":"Host immune response to infection and cancer: unexpected commonalities","volume":"15","author":"Goldszmid","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B70","doi-asserted-by":"publisher","first-page":"625","DOI":"10.14740\/jocmr2606w","article-title":"Systemic sclerosis and malignancy: a review of current data","volume":"8","author":"Zeineddine","year":"2016","journal-title":"J Clin Med Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"84508","DOI":"10.18632\/oncotarget.13022","article-title":"MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgt333","article-title":"Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors","volume":"35","author":"Tahiri","year":"2014","journal-title":"Carcinogenesis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.leukres.2014.11.001","article-title":"miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias","volume":"39","author":"Riccioni","year":"2015","journal-title":"Leuk Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1182\/blood-2011-09-378687","article-title":"The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice","volume":"119","author":"Li","year":"2012","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s13277-015-4150-3","article-title":"MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN","volume":"37","author":"Ren","year":"2016","journal-title":"Tumour Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1200\/JCO.2012.48.3180","article-title":"miR-155 in acute myeloid leukemia: not merely a prognostic marker?","volume":"31","author":"Joyce","year":"2013","journal-title":"J Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.bbrc.2009.12.098","article-title":"miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7","volume":"391","author":"Sun","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cdd.2017.159","article-title":"BCL2 and miR-15\/16: from gene discovery to treatment","volume":"25","author":"Pekarsky","year":"2017","journal-title":"Cell Death Differ"},{"key":"B79","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","article-title":"Apoptosis in cancer","volume":"21","author":"Lowe","year":"2000","journal-title":"Carcinogenesis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.coph.2004.03.008","article-title":"The Fas signalling pathway and its role in the pathogenesis of cancer","volume":"4","author":"Houston","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1478-811X-11-97","article-title":"Targeting the PDGF signaling pathway in tumor treatment","volume":"11","author":"Heldin","year":"2013","journal-title":"Cell Commun Signal"},{"key":"B83","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/35078555","article-title":"Regulation of c-myc expression by PDGF through Rho GTPases","volume":"3","author":"Chiariello","year":"2001","journal-title":"Nat Cell Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E151","DOI":"10.3390\/genes8060151","article-title":"MYC deregulation in primary human cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes"},{"key":"B85","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13547500701674063","article-title":"Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review","volume":"13","author":"Bien","year":"2008","journal-title":"Biomarkers"},{"key":"B87","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.autrev.2017.07.001","article-title":"Does type-I interferon drive systemic autoimmunity?","volume":"16","author":"Picard","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fimmu.2013.00266","article-title":"The role of type 1 interferon in systemic sclerosis","volume":"4","author":"Wu","year":"2013","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I interferon in chronic virus infection and cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1182\/blood-2006-04-014480","article-title":"Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation","volume":"109","author":"Atanackovic","year":"2007","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/gene.2014.44","article-title":"Emerging role of epigenetics in systemic sclerosis pathogenesis","volume":"15","author":"Ciechomska","year":"2014","journal-title":"Genes Immun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"42899","DOI":"10.1038\/srep42899","article-title":"Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/ddr.21257","article-title":"The role of miR-21 in Cancer","volume":"76","author":"Pfeffer","year":"2015","journal-title":"Drug Dev Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-016-1054-6","article-title":"miR-155 in the progression of lung fibrosis in systemic sclerosis","volume":"18","author":"Christmann","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B96","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cdd.2009.69","article-title":"miR-15a and miR-16-1 in cancer: discovery, function and future perspectives","volume":"17","author":"Aqeilan","year":"2010","journal-title":"Cell Death Differ"},{"key":"B97","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00449\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T23:24:46Z","timestamp":1520292286000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00449\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2018.00449"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00449","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"article-number":"449"}}